BlackThorn Therapeutics Garners $40,000,000 Series A Round

  • Feed Type
  • Date
    10/21/2016
  • Company Name
    BlackThorn Therapeutics
  • Mailing Address
    329 Oyster Point Blvd 3rd Floor South San Francisco, CA 94080 USA
  • Company Description
    BlackThorn Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the lives of people with neurobehavioral disorders through the discovery and development of novel, targeted treatments.
  • Website
    http://www.blackthornrx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $40,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    ARCH Venture Partners
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    Altitude Life Science Ventures
  • Venture Investor
    Mercury Fund
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    Undisclosed

Trending on Xconomy